ASP Isotopes Inc. Common Stock·Basic Materials
ASP Isotopes Inc., a pre-commercial stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It develops Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company also Uranium-235, an isotope of uranium for carbon-free energy industry. ASP Isotopes Inc. was incorporated in 2021 and is based in Boca Raton, Florida.
ASP Isotopes Inc. (NASDAQ:ASPI) shares are trading higher Tuesday after the company announced it restarted the first 18 states of its Silicon-28 enrichment facilities in Pretoria, South Africa.
ASP Isotopes has previously announced that it has signed three commercial contracts for the supply of enriched Silicon-28 to U.S.-based customers, and expects to make initial commercial shipments of enriched Silicon-28 in Q3 2026. The first 18 stages (comprising segments one and two) of the Silicon-28 enrichment facility have now successfully operated for over three weeks at target enrichment levels.

ASP Isotopes Inc. (NASDAQ:ASPI) shares are trading higher Monday after the company announced that its subsidiary, Quantum Leap Energy LLC, entered into a non-binding Memorandum of Understanding with a European nuclear technology company for advanced nuclear fuel supply collaboration.

MOU establishes framework for collaboration with the goal to supply HALEU to European advanced reactor developer, beginning 2028 MOU establishes framework for collaboration with the goal to supply HALEU to European advanced reactor developer, beginning 2028

Technology Commercialization Leader Expected to Enhance QLE's Government Partnerships and Advanced Materials Strategy Technology Commercialization Leader Expected to Enhance QLE's Government Partnerships and Advanced Materials Strategy

ASP Isotopes Inc. (NASDAQ: ASPI - Get Free Report) Director Duncan Moore sold 11,642 shares of ASP Isotopes stock in a transaction that occurred on Thursday, April 16th. The stock was sold at an average price of $5.21, for a total value of $60,654.82. Following the sale, the director owned 1,044,928 shares in the company, valued